Oncology
1832 CE, England (Thomas Hodgkin's paper in Medico-Chirurgical Transactions, though lymph node swelling descriptions date to antiquity)
Hodgkin's disease, a malignancy of the lymphatic system, was first distinguished as a discrete pathological entity in the early nineteenth century through the work of a London physician whose name the condition came to bear. Before its formal identification, swellings of the lymph nodes had been observed and described across centuries of medical writing, though they were generally attributed to tuberculosis, syphilis, or other infectious conditions rather than recognized as a separate disease. The subsequent century of pathological and clinical investigation transformed Hodgkin's disease from a poorly understood curiosity into one of the most studied lymphatic malignancies in medical history.
Historical Narrative
Enlarged lymph nodes and swellings of the neck and armpits had been documented since antiquity, described by Hippocratic physicians under the general category of scrofula and by Galen within his humoral framework as accumulations of corrupted phlegm or black bile. Throughout the medieval period, swollen lymph nodes were most commonly attributed to tuberculosis or to syphilis after that disease's widespread appearance in Europe in the late fifteenth century, and healers attempted treatments ranging from herbal poultices to cauterization and surgical excision.
The pivotal moment in the distinct history of Hodgkin's disease came in 1832, when Thomas Hodgkin, a pathologist and curator of the museum at Guy's Hospital in London, published a paper in the Medico-Chirurgical Transactions describing the post-mortem findings of six patients who had exhibited a striking pattern of lymph node and spleen enlargement during life. Hodgkin's paper, titled 'On Some Morbid Appearances of the Absorbent Glands and Spleen,' argued that these cases represented a primary disease of the lymphatic system rather than a secondary consequence of tuberculosis or another known condition. The work attracted limited immediate attention and its significance was not widely appreciated in Hodgkin's own lifetime.
It was Samuel Wilks, another physician at Guy's Hospital, who returned to Hodgkin's original cases in 1865 and, after independently describing additional patients with similar presentations, formally named the condition Hodgkin's disease in recognition of his predecessor's priority. Wilks's endorsement and his expanded clinical descriptions brought the condition into wider medical consciousness and established the eponymous designation that persisted through subsequent medical history.
The histological characterization of Hodgkin's disease advanced significantly in the late nineteenth and early twentieth centuries. In 1898, Carl Sternberg in Vienna described the large, distinctive multinucleated cells observed in the lymph nodes of affected patients, and Dorothy Reed at Johns Hopkins independently described the same cells in 1902, providing a reproducible microscopic criterion for pathological diagnosis. These cells subsequently bore both investigators' names and became central to the pathological identification of the condition in autopsy and biopsy specimens throughout the twentieth century.
Early therapeutic attempts relied on surgical excision of accessible lymph nodes and, from the late nineteenth century onward, on the newly discovered properties of radiation following Wilhelm Röntgen's 1895 discovery of X-rays. René Gilbert in Geneva and later Henry Kaplan at Stanford pioneered increasingly systematic approaches to radiation therapy for lymphatic malignancies during the first half of the twentieth century, with Kaplan's work in the 1950s and 1960s demonstrating that carefully mapped radiation fields could achieve sustained remissions in a significant proportion of patients, fundamentally altering the prognosis associated with the disease.
Paralleling these radiological advances, investigators in the mid-twentieth century worked to develop staging systems that could classify the extent of disease at the time of diagnosis. The Ann Arbor staging classification, formalized in 1971 following an international conference, represented a culmination of decades of clinical observation and became the standard framework through which physicians organized both prognosis and the selection of treatment approaches in the latter twentieth century.
Key Historical Figures
Historical narrative only — this page describes how Hodgkin's disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.